Anionic sulphur (SH-also termed sulphide) together with protein thiols and other sulphur species are essential for anaerobic bacteria of the fermentative organs to maintain anaerobiosis1 2 and ensure production of short chain fatty acids. [3] [4] [5] Most sulphide in the colon is produced by the anaerobic sulphate reducing bacteria, which require sulphate6 to facilitate removal of hydrogen produced by anaerobic bacteria in the colon,7-9 a process in which methane producing bacteria act competitively.10-2 The source of colonic sulphur is either ingested sulphate13 or sulphur extracted transmucosally from the circulation by the intestine.21 '7 The injurious potential of sulphur species in the colon was initially deduced from the ability of sulphated dextrans but not dextrans without sulphur to induce experimental colitis and colon cancer.18 19 From a number of sulphur containing agents, sulphides proved most injurious to isolated human colonocytes20 by a mechanism proposed in part to be due to persulphide formation of activated SCFAs.21 Additional studies in humans showed that luminal sulphide concentrations in ulcerative colitis exceed that of control patients22 and that ulcerative colitis patients produce more sulphide from fermentative substrates compared with control patients.23 A role for sulphide in the causation of ulcerative colitis therefore seemed possible.
Protective mechanisms against the damaging effect of luminal sulphide exist in colonocytes.
Methylation of sulphide24 25 leads to the less toxic derivatives methanethiol and dimethylsulphide,20 an action facilitated by thiol methyltransferases acting on S-adenosylmethionine (SAM) for which methionine is a precursor.26
Thiol methyltransferase activity is high in human colonocytes24 25 and methionine has been shown in preliminary rat experiments to be protective against the impairment of acute oxidative damage induced by sulphides in colonocytes.21
The aim of this study was to assess the remedial effect of methionine and methionine derivatives on suppression of oxidative metabolism produced by sulphides in rat and human colonocytes. The findings with sulphides and methionine are related to the disease process of ulcerative colitis.
Methods
Chemicals and reagents Sodium n-butyrate was obtained from BDH (Melbourne, Australia) and sodium hydrogen sulphide (NaHS) from Ajax Chemicals (Sydney, Australia). L-Methionine was from Calbiochem (San Diego, USA). S-adenosylmethionine 1,4 butane disulphonate (SAMe), a stable salt of SAM was a gift from BioResearch Spa, Milan, Italy. DL-methionine-S-methyl sulphonium chloride (MMC) was obtained from Sigma, North Ryde, was trapped in 0.5 ml of 2 M NaOH injected into the centre well immediately after cell proteins were precipitated with perchloric acid. Flasks were gently shaken on ice for 1 1/2 hours, and 0.1 ml of the solution was added to 5 ml of scintillant as previously described.20 Samples were counted in a Beckman scintillation counter (Beckman Instruments, Irvine, CA), and counts were corrected for non-specific activity or volatility of the fatty acid n-butyrate.
Expression of results and statistics Formation of metabolites by colonocytes was expressed per gram dry weight rather than unit protein, DNA or number of cells because production of hydrated mucus is variable and leads to clumping of cells. Dry weight of cells was obtained by drying 1 ml of suspension to constancy at 100°C and corrected for the dry weight of albumin contained in the medium. 14C02 generation from fatty acid was calculated from the specific activities and trapped 14C02 in sodium hydroxide.
Observations were obtained from the same tissue on which parallel experiments were performed and these were subjected to Student's paired t test, the 0.05 probability level was taken to mean a significant difference in observations.
Results
Sodium hydrogen sulphide acting on colonocytes of the rat dose dependently reduced CO2 and acetoacetate production from n-butyrate (Table I) Student's paired t test: *NS, tp<00 1 and *p<O-001 compared with no NaHS. §NS, 1lp<O0 1, and ¶p<0025 compared with 1-00 mmol/l NaHS alone. 'p<001 compared with 1-5 mmol/l NaHS alone. imal and distal colon exposed to sodium hydrogen sulphide showed a linear reduction in CO2 production from n-butyrate and at all observed concentrations L-methionine significantly improved CO, production in colonocytes exposed to SH- (Fig 1) . (Fig 2) . Acetoacetate production was also improved by SAMe and methionine (Table II) . SAMe was significantly better (p<001) than L-methionine in improving CO2 production from butyrate by impaired human colonocytes (2.0 mmol/l NaHS).
Discussion
The relation between the concentration of hydrogen sulphide and suppression of CO2 In the colonic mucosa the free amino acid level of methionine is low compared with other amino acids31 nevertheless the colonic mucosa extracts methionine from the circulation,14 15 at a rate that is increased under conditions of surgical stress, for methionine, alanine, and glutamine but not other amino acids.32
Very little methionine is normally absorbed from the colonic lumen of the mammalian colon.33 In enterocytes and colonocytes methionine is the precursor for glutathione34 35 that acts as an antioxidant36 and also is the precursor of S-adenosylmethionine26 that acts as an antireductant through its action of methylation24 25 (Fig 3) . The formation of S-adenosylmethionine in colonocytes requires adenosine triphosphate and methionine with appropriate enzymes.37 Methionine that is not converted to SAM in bodily tissues is con- verted to sulphate by hepatocytes38 39 and the sulphate returned to the intestinal lumen by a rapid transport system that extracts sulphate from the circulation.14-16 The sulphate in the intestinal lumen derived from the circulation will be subjected to fermentative action by sulphate reducing bacteria in the colon and increased sulphide production may result (Fig 3) .
SAM is the universal methylating agent of sulphur, carbon, and nitrogen groups ofvarious chemical compounds37 and has been therapeutically used for the treatment of depression,40 osteoarthritis,41 and liver diseases.40 The drug action is postulated to be through methylation processes of cell membranes or replenishment of depleted glutathione stores.4' 42 MMC has been successfully used to treat ulcerative colitis43 and proposed to counteract the depleted glutathione levels found in the mucosa of ulcerative colitis.44 Based on present observations methylation of toxic sulphides could also account for the utility of this drug in ulcerative colitis. Yet a further consideration is that SAM via methylation changes Na+ +K+ ATPase in colonocytes45 to promote ion absorption suggesting that methylation could act to control entry of anionic sulphide into colonocytes.
That sulphide toxicity might initiate ulcerative colitis is hypothetical yet a number of biochemical, microbiological, and epidemiological findings support such a possibility. Sulphide concentrations in the colonic lumen are higher in cases of ulcerative colitis than control cases.22 Sulphate reducing bacteria from ulcerative colitis cases produce more H2S from fermentative substrates and have more robust growth characteristics than those compared with control cases.23 Sulphate reducing bacteria are found less frequently in rural black population groups where the prevalence of ulcerative colitis is very low compared with the population groups in the United Kingdom4647 where the prevalence of ulcerative colitis is high. Biochemically sulphides selectively inhibit n-butyrate oxidation21 the main nutrient of colonocytes and sulphides are more toxic to colonocytes of the distal colon20 where colitis is found more frequently. Present results show that sulphide has a graded damaging effect on colonocytes according to concentration of sulphide and that the damaging effect is partially reversible by methionine and SAMe. The most efficacious drug for ulcerative colitis, 5-ASA has now been shown to inhibit sulphide formation by colonic bacteria in humans. [48] [49] [50] The precise mode whereby sulphide might act in the pathogenesis of ulcerative colitis remains unknown -overproduction of sulphide or diminished detoxification each or both require investigation.
In considering either L-methionine or SAM for clinical use in ulcerative colitis, L-methionine would be undesirable for such purposes as adenosine triphosphate levels in colonocytes to generate SAM from methionine (Fig 3) are diminished in acute colitis51 and consequently excess L-methionine would be converted to sulphate in the liver.38 Re-entry of such sulphate into the intestinal tract16 would increase sulphide formation in the colon. The functions of methionine with regard to colonocytes seems delicately poised between a useful and a potentially harmful role (Fig 3) . The application of SAMe as a therapeutic agent is warranted in view of the current finding of protection against sulphide toxicity. The place of sulphide in the pathogenesis of ulcerative colitis requires further detailed investigation both at a cellular-biochemical and clinicaltherapeutic level.
